MedTrace Logo

Hypertonic Saline Dextran in Pediatric Cardiac Surgery

NCT00199771 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2011-07-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether infusion of hypertonic saline dextran attenuates the inflammatory response and the water overload, during and after major cardiac surgery in small children.

Conditions

  • Heart Defects, Congenital
  • Transposition of Great Vessels
  • Heart Septal Defects, Ventricular
  • Endocardial Cushion Defects

Interventions

DRUG

7.5% NaCl in 6% dextran 70 solution

Sponsors & Collaborators

  • BioPhausia

    collaborator INDUSTRY

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Bentsen, MD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
16 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2004-12-31
Completion
2005-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00199771 on ClinicalTrials.gov